Deep Learning to Distinguish Benign from Malignant Renal Lesions Based on Routine MR Imaging.
Ianto Lin XiYijun ZhaoRobin WangMarcello ChangSubhanik PurkayasthaRaymond Y HuangAlvin C SilvaMartin VallièresPeiman HabibollahiYong FanBeiji ZouTerence P F GadePaul J ZhangMichael C SoulenZishu ZhangHarrison X BaiS William StavropoulosPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
Deep learning can noninvasively distinguish benign renal tumors from RCC using conventional MR imaging in a multi-institutional dataset with good accuracy, sensitivity, and specificity comparable with experts and radiomics.